Industries > Pharma > Global Cancer Immunotherapy Market to 2027

Global Cancer Immunotherapy Market to 2027

Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer

PUBLISHED: 11 December 2017
PAGES: 165
PRODUCT CODE: PHA0266

Clear
WOOCS 2.2.1

The world cancer immunotherapy market is expected to grow at a CAGR of 12.6% in the second half of the forecast period. The market reached $51.9bn in 2016, dominated by the monoclonal antibody segment which held 66.7% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 165-page report you will receive 95 tables and 94 figures– all unavailable elsewhere.

The 165-page report provides clear detailed insight into the world cancer-treating drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

World cancer immunotherapy market forecasts to 2027

• This report also breaks down the revenue forecast for the world cancer immunotherapy market by Technology:
– Monoclonal Antibodies
– Cytokines & immunomodulators
– Others (Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy)

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.

• This report also breaks down the revenue forecast for the world cancer immunotherapy market by Application:
– Lung Cancer
– Breast Cancer
– Colorectal cancer
– Melanoma Cancer
– Prostate Cancer
– Head & Neck Cancer,
– Others (Renal Cell Carcinoma, Cervical, Gastric, Lymphoma)

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.

• This report also breaks down the revenue forecast for the world cancer immunotherapy market by End User:
– Hospitals
– Cancer Research Centers
– Clinics

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– North America:
US, Canada, Mexico
– South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
– Europe: The UK, Germany, France, Spain, Italy, Rest of Europe
– Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
– Rest of World: Middle East, Africa, Other Countries

Global Cancer Immunotherapy Market to 2027

• This report discusses trends in the industry and assesses drivers and restraints, as well as opportunities and threats. It also includes porters five force analysis; threat of new entrants, power of suppliers, power of buyers, rivalry among competitors and threat of substituents.

• Our study discusses the selected leading companies that are the major players in the cancer immunotherapy market:
– AstraZeneca
– Merck & Co., Inc. (Merck)
– Novartis
– Bristol-Myers Squibb (BMS)
– Roche
– Eli Lilly and Co.
– Pfizer
– Bayer
– Adaxic Inc
– Medtronic Plc

The report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments.

Visiongain’s study is intended for anyone requiring commercial analyses for the world Cancer Immunotherapy market. You find data, trends and predictions.

Buy our report today Global Cancer Immunotherapy Market to 2027: Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Cancer Immunotherapy Market to 2027


Download sample pages

Complete the form below to download your free sample pages for Global Cancer Immunotherapy Market to 2027


Latest Pharma news

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

READ

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

READ

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

READ

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

READ

Categories